Arcadia Biosciences (NASDAQ:RKDA) Share Price Crosses Below 50-Day Moving Average – What’s Next?

Arcadia Biosciences, Inc. (NASDAQ:RKDAGet Free Report)’s share price passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $3.26 and traded as low as $2.25. Arcadia Biosciences shares last traded at $2.26, with a volume of 32,820 shares traded.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Arcadia Biosciences in a report on Monday, December 29th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.

Get Our Latest Research Report on Arcadia Biosciences

Arcadia Biosciences Stock Down 8.1%

The stock has a fifty day moving average of $3.26 and a two-hundred day moving average of $3.78. The stock has a market cap of $3.10 million, a price-to-earnings ratio of 0.89 and a beta of 0.57.

Arcadia Biosciences (NASDAQ:RKDAGet Free Report) last released its quarterly earnings data on Friday, November 7th. The basic materials company reported $0.62 EPS for the quarter, topping analysts’ consensus estimates of ($0.54) by $1.16. The company had revenue of $1.30 million for the quarter, compared to the consensus estimate of $1.90 million. Arcadia Biosciences had a negative return on equity of 8.80% and a negative net margin of 97.97%.

About Arcadia Biosciences

(Get Free Report)

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.

See Also

Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.